Table 1.

Characteristics of study population

Parameters	Number (%)
Age (mean age: 9.6 (1–30 years)
≤15 years	22 (84.6%)
>15 years	4 (15.4%)
Severity of hemophilia
Severe	8 (30.8%)
Moderate	9 (34.6%)
Mild	9 (34.6%)
Treatment history by factor VIII concentrates
Patients treated	25 (96%)
Patients untreated	1 (4%)
Number of exposure days to factor VIII concentrates
1–10 days	20 (76%)
11–20 days	2 (8%)
21–30 days	4 (16%)
Anti factor VIII inhibitors
Patients with inhibitors	4 (15.3%)
Patients without inhibitors	22 (84.7%)